-
2
-
-
84870328109
-
Exercise strengthens circadian clocks
-
Harrington ME: Exercise strengthens circadian clocks. J Physiol 590: 5929, 2012.
-
(2012)
J Physiol
, vol.590
, pp. 5929
-
-
Harrington, M.E.1
-
3
-
-
0041346143
-
Circadian rhythms. Clocks on the brain
-
Green CB and Menaker M: Circadian rhythms. Clocks on the brain. Science 301: 319-320, 2003.
-
(2003)
Science
, vol.301
, pp. 319-320
-
-
Green, C.B.1
Menaker, M.2
-
4
-
-
0032956319
-
Cellular circadian clocks in the pineal
-
Falcon J: Cellular circadian clocks in the pineal. Prog Neurobiol 58: 121-162, 1999.
-
(1999)
Prog Neurobiol
, vol.58
, pp. 121-162
-
-
Falcon, J.1
-
5
-
-
0034982529
-
Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer
-
Stevens RG and Rea MS: Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12: 279-287, 2001.
-
(2001)
Cancer Causes Control
, vol.12
, pp. 279-287
-
-
Stevens, R.G.1
Rea, M.S.2
-
6
-
-
33645498504
-
Risk of breast cancer after night-and shift work: Current evidence and ongoing studies in Denmark
-
Hansen J: Risk of breast cancer after night-and shift work: Current evidence and ongoing studies in Denmark. Cancer Causes Control 17: 531-537, 2006.
-
(2006)
Cancer Causes Control
, vol.17
, pp. 531-537
-
-
Hansen, J.1
-
7
-
-
0037704257
-
Night-shift work and risk of colorectal cancer in the nurses' health study
-
Schernhammer ES, Laden F, Speizer FE, et al: Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95: 825-828, 2003.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 825-828
-
-
Schernhammer, E.S.1
Laden, F.2
Speizer, F.E.3
-
8
-
-
0345707584
-
The days and nights of cancer cells
-
Canaple L, Kakizawa T and Laudet V: The days and nights of cancer cells. Cancer Res 63: 7545-7552, 2003.
-
(2003)
Cancer Res
, vol.63
, pp. 7545-7552
-
-
Canaple, L.1
Kakizawa, T.2
Laudet, V.3
-
9
-
-
27944472296
-
Circadian function in patients with advanced non-small-cell lung cancer
-
Levin RD, Daehler MA, Grutsch JF, et al: Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 93: 1202-1208, 2005.
-
(2005)
Br J Cancer
, vol.93
, pp. 1202-1208
-
-
Levin, R.D.1
Daehler, M.A.2
Grutsch, J.F.3
-
10
-
-
77953520230
-
Circadian rhythms and cancer
-
Gery S and Koeffler HP: Circadian rhythms and cancer. Cell Cycle 9: 1097-1103, 2010.
-
(2010)
Cell Cycle
, vol.9
, pp. 1097-1103
-
-
Gery, S.1
Koeffler, H.P.2
-
11
-
-
84863494541
-
Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review)
-
Leonardi GC, Rapisarda V, Marconi A, et al: Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review). Oncol Rep 28: 418-428, 2012.
-
(2012)
Oncol Rep
, vol.28
, pp. 418-428
-
-
Leonardi, G.C.1
Rapisarda, V.2
Marconi, A.3
-
12
-
-
80053102580
-
Disrupting the circadian clock: Genespecific effects on aging, cancer, and other phenotypes
-
Yu EA and Weaver DR: Disrupting the circadian clock: Genespecific effects on aging, cancer, and other phenotypes. Aging (Albany, NY) 3: 479-493, 2011.
-
(2011)
Aging (Albany, NY)
, vol.3
, pp. 479-493
-
-
Yu, E.A.1
Weaver, D.R.2
-
13
-
-
77950408376
-
Circadian rhythm and its role in malignancy
-
Rana S and Mahmood S: Circadian rhythm and its role in malignancy. J Circadian Rhythms 8: 3, 2010.
-
(2010)
J Circadian Rhythms
, vol.8
, pp. 3
-
-
Rana, S.1
Mahmood, S.2
-
14
-
-
77950903271
-
Circadian clocks and vascular function
-
Paschos GK and FitzGerald GA: Circadian clocks and vascular function. Circ Res 106: 833-841, 2010.
-
(2010)
Circ Res
, vol.106
, pp. 833-841
-
-
Paschos, G.K.1
FitzGerald, G.A.2
-
15
-
-
52149109334
-
The genetics of mammalian circadian order and disorder: Implications for physiology and disease
-
Takahashi JS, Hong HK, Ko CH and McDearmon EL: The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat Rev Genet 9: 764-775, 2008.
-
(2008)
Nat Rev Genet
, vol.9
, pp. 764-775
-
-
Takahashi, J.S.1
Hong, H.K.2
Ko, C.H.3
McDearmon, E.L.4
-
16
-
-
34247515224
-
Riding tandem: Circadian clocks and the cell cycle
-
Hunt T and Sassone-Corsi P: Riding tandem: Circadian clocks and the cell cycle. Cell 129: 461-464, 2007.
-
(2007)
Cell
, vol.129
, pp. 461-464
-
-
Hunt, T.1
Sassone-Corsi, P.2
-
17
-
-
33644617485
-
Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions
-
Ripperger JA and Schibler U: Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet 38: 369-374, 2006.
-
(2006)
Nat Genet
, vol.38
, pp. 369-374
-
-
Ripperger, J.A.1
Schibler, U.2
-
18
-
-
83655184641
-
Altered expression of circadian clock genes in head and neck squamous cell carcinoma
-
Hsu CM, Lin SF, Lu CT, Lin PM and Yang MY: Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol 33: 149-155, 2012.
-
(2012)
Tumour Biol
, vol.33
, pp. 149-155
-
-
Hsu, C.M.1
Lin, S.F.2
Lu, C.T.3
Lin, P.M.4
Yang, M.Y.5
-
19
-
-
53849124685
-
Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer
-
Tokunaga H, Takebayashi Y, Utsunomiya H, et al: Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstet Gynecol Scand 87: 1060-1070, 2008.
-
(2008)
Acta Obstet Gynecol Scand
, vol.87
, pp. 1060-1070
-
-
Tokunaga, H.1
Takebayashi, Y.2
Utsunomiya, H.3
-
20
-
-
33750377047
-
Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3
-
Yang MY, Chang JG, Lin PM, et al: Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3. Cancer Sci 97: 1298-1307, 2006.
-
(2006)
Cancer Sci
, vol.97
, pp. 1298-1307
-
-
Yang, M.Y.1
Chang, J.G.2
Lin, P.M.3
-
21
-
-
80053144962
-
A decade of exploring the cancer epigenome -biological and translational implications
-
Baylin SB and Jones PA: A decade of exploring the cancer epigenome -biological and translational implications. Nat Rev Cancer 11: 726-734, 2011.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 726-734
-
-
Baylin, S.B.1
Jones, P.A.2
-
22
-
-
84879249639
-
Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells
-
Seisenberger S, Peat JR and Reik W: Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells. Curr Opin Cell Biol 25: 281-288, 2013.
-
(2013)
Curr Opin Cell Biol
, vol.25
, pp. 281-288
-
-
Seisenberger, S.1
Peat, J.R.2
Reik, W.3
-
23
-
-
33748297582
-
Histone modifications silence the GATA transcription factor genes in ovarian cancer
-
Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT and Xu XX: Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene 25: 5446-5461, 2006.
-
(2006)
Oncogene
, vol.25
, pp. 5446-5461
-
-
Caslini, C.1
Capo-chichi, C.D.2
Roland, I.H.3
Nicolas, E.4
Yeung, A.T.5
Xu, X.X.6
-
24
-
-
0037354548
-
Epigenetic regulation of ARHI in breast and ovarian cancer cells
-
Yu Y, Fujii S, Yuan J, et al: Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann NY Acad Sci 983: 268-277, 2003.
-
(2003)
Ann NY Acad Sci
, vol.983
, pp. 268-277
-
-
Yu, Y.1
Fujii, S.2
Yuan, J.3
-
25
-
-
27144499187
-
Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer
-
Chan MW, Wei SH, Wen P, et al: Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer. Clin Cancer Res 11: 7376-7383, 2005.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7376-7383
-
-
Chan, M.W.1
Wei, S.H.2
Wen, P.3
-
26
-
-
50849154478
-
Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer
-
Chan MW, Huang YW, Hartman-Frey C, et al: Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. Neoplasia 10: 908-919, 2008.
-
(2008)
Neoplasia
, vol.10
, pp. 908-919
-
-
Chan, M.W.1
Huang, Y.W.2
Hartman-Frey, C.3
-
27
-
-
77649092118
-
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
-
Chou JL, Su HY, Chen LY, et al: Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest 90: 414-425, 2010.
-
(2010)
Lab Invest
, vol.90
, pp. 414-425
-
-
Chou, J.L.1
Su, H.Y.2
Chen, L.Y.3
-
28
-
-
79958741371
-
Aberrant TGFbeta/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer
-
Yeh KT, Chen TH, Yang HW, et al: Aberrant TGFbeta/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer. Epigenetics 6: 727-739, 2011.
-
(2011)
Epigenetics
, vol.6
, pp. 727-739
-
-
Yeh, K.T.1
Chen, T.H.2
Yang, H.W.3
-
29
-
-
58249087346
-
An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
-
Su HY, Lai HC, Lin YW, Chou YC, Liu CY and Yu MH: An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 124: 387-393, 2009.
-
(2009)
Int J Cancer
, vol.124
, pp. 387-393
-
-
Su, H.Y.1
Lai, H.C.2
Lin, Y.W.3
Chou, Y.C.4
Liu, C.Y.5
Yu, M.H.6
-
30
-
-
0037105657
-
Periostin secreted by epithelial ovarian carcinoma is a ligand for aVβ3 and aVβ5 integrins and promotes cell motility
-
Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY and Chang DD: Periostin secreted by epithelial ovarian carcinoma is a ligand for aVβ3 and aVβ5 integrins and promotes cell motility. Cancer Res 62: 5358-5364, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 5358-5364
-
-
Gillan, L.1
Matei, D.2
Fishman, D.A.3
Gerbin, C.S.4
Karlan, B.Y.5
Chang, D.D.6
-
31
-
-
84870573126
-
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
-
McCabe MT, Ott HM, Ganji G, et al: EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492: 108-112, 2012.
-
(2012)
Nature
, vol.492
, pp. 108-112
-
-
McCabe, M.T.1
Ott, H.M.2
Ganji, G.3
-
32
-
-
0037184940
-
The circadian gene period2 plays an important role in tumor suppression and DNA-damage response in vivo
-
Fu LN, Pelicano H, Liu JS, Huang P and Lee CC: The circadian gene period2 plays an important role in tumor suppression and DNA-damage response in vivo. Cell 111: 1055-1055, 2002.
-
(2002)
Cell
, vol.111
, pp. 1055-1055
-
-
Fu, L.N.1
Pelicano, H.2
Liu, J.S.3
Huang, P.4
Lee, C.C.5
-
33
-
-
0037711399
-
The circadian clock: Pacemaker and tumour suppressor
-
Fu L and Lee CC: The circadian clock: Pacemaker and tumour suppressor. Nat Rev Cancer 3: 350-361, 2003.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 350-361
-
-
Fu, L.1
Lee, C.C.2
-
34
-
-
53349145764
-
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response
-
Hoffman AE, Zheng T, Ba Y and Zhu Y: The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res 6: 1461-1468, 2008.
-
(2008)
Mol Cancer Res
, vol.6
, pp. 1461-1468
-
-
Hoffman, A.E.1
Zheng, T.2
Ba, Y.3
Zhu, Y.4
-
35
-
-
33947422161
-
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer
-
Gery S, Komatsu N, Kawamata N, et al: Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res 13: 1399-1404, 2007.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1399-1404
-
-
Gery, S.1
Komatsu, N.2
Kawamata, N.3
-
36
-
-
70350539563
-
Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies
-
Taniguchi H, Fernandez AF, Setien F, et al: Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res 69: 8447-8454, 2009.
-
(2009)
Cancer Res
, vol.69
, pp. 8447-8454
-
-
Taniguchi, H.1
Fernandez, A.F.2
Setien, F.3
-
37
-
-
33749259773
-
Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR
-
Shih MC, Yeh KT, Tang KP, Chen JC and Chang JG: Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol Carcinog 45: 732-740, 2006.
-
(2006)
Mol Carcinog
, vol.45
, pp. 732-740
-
-
Shih, M.C.1
Yeh, K.T.2
Tang, K.P.3
Chen, J.C.4
Chang, J.G.5
-
38
-
-
62849106294
-
A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway
-
Mullenders J, Fabius AW, Madiredjo M, Bernards R and Beijersbergen RL: A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PloS one 4: E4798, 2009.
-
(2009)
PloS one
, vol.4
, pp. e4798
-
-
Mullenders, J.1
Fabius, A.W.2
Madiredjo, M.3
Bernards, R.4
Beijersbergen, R.L.5
-
39
-
-
84876254318
-
Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway
-
Jung CH, Kim EM, Park JK, et al: Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep 29: 2109-2113, 2013.
-
(2013)
Oncol Rep
, vol.29
, pp. 2109-2113
-
-
Jung, C.H.1
Kim, E.M.2
Park, J.K.3
-
40
-
-
18644382388
-
The polycomb group protein EZH2 is involved in progression of prostate cancer
-
Varambally S, Dhanasekaran SM, Zhou M, et al: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629, 2002.
-
(2002)
Nature
, vol.419
, pp. 624-629
-
-
Varambally, S.1
Dhanasekaran, S.M.2
Zhou, M.3
-
41
-
-
0141816752
-
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
-
Kleer CG, Cao Q, Varambally S, et al: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100: 11606-11611, 2003.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 11606-11611
-
-
Kleer, C.G.1
Cao, Q.2
Varambally, S.3
-
42
-
-
32844459336
-
The Polycomb group protein EZH2 directly controls DNA methylation
-
Vire E, Brenner C, Deplus R, et al: The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874, 2006.
-
(2006)
Nature
, vol.439
, pp. 871-874
-
-
Vire, E.1
Brenner, C.2
Deplus, R.3
|